GlycoMimetics Inc. (NASDAQ: GLYC)
$0.32
+0.0050 ( +1.61% ) 1.0M
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Market Data
Open
$0.32
Previous close
$0.31
Volume
1.0M
Market cap
$20.38M
Day range
$0.31 - $0.33
52 week range
$0.24 - $3.53
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 01, 2024 |
4 | Insider transactions | 1 | May 01, 2024 |
4 | Insider transactions | 1 | May 01, 2024 |
4 | Insider transactions | 1 | May 01, 2024 |
4 | Insider transactions | 1 | May 01, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
ars | Annual reports | 1 | Apr 01, 2024 |
def | Proxies and info statements | 6 | Apr 01, 2024 |